BioCorRx Inc. (BICX)
OTCMKTS: BICX · Delayed Price · USD
1.470
0.00 (0.00%)
Apr 16, 2024, 1:00 PM EDT - Market closed
BioCorRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.09 | 0.21 | 0.05 | 0.12 | 0.24 | 0.38 | 0.66 | 0.7 | 0.92 | 1.17 | Upgrade
|
| Revenue Growth (YoY) | -58.31% | 342.99% | -60.63% | -48.96% | -36.21% | -42.69% | -6.34% | -24.11% | -21.03% | 63.77% | Upgrade
|
| Cost of Revenue | 0.24 | 0.02 | 0.01 | 0.1 | 0.08 | 0.17 | 0.32 | 0.18 | 0.15 | 0.22 | Upgrade
|
| Gross Profit | -0.15 | 0.2 | 0.04 | 0.03 | 0.16 | 0.21 | 0.33 | 0.53 | 0.77 | 0.95 | Upgrade
|
| Selling, General & Admin | 2.7 | 3.41 | 3.74 | 3.17 | 4.57 | 4.42 | 2.74 | 2.55 | 2.13 | 3.87 | Upgrade
|
| Research & Development | 0.89 | 1.46 | 1.61 | 4.27 | 1.13 | 0.15 | 0.45 | 0 | 0 | 0 | Upgrade
|
| Other Operating Expenses | 0.01 | -1.76 | -0.77 | -4.39 | -1.06 | 0.01 | 0.03 | 0.03 | 0.13 | 0.14 | Upgrade
|
| Operating Expenses | 3.59 | 3.11 | 4.58 | 3.05 | 4.63 | 4.58 | 3.22 | 2.58 | 2.25 | 4 | Upgrade
|
| Operating Income | -3.74 | -2.91 | -4.53 | -3.03 | -4.47 | -4.63 | -2.89 | -2.18 | -5.12 | -3.05 | Upgrade
|
| Interest Income | 0 | 1.09 | 0.57 | 0.51 | 1.62 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Expense | 0.89 | 1.09 | 0.57 | 0.51 | 1.62 | 1.96 | -11.15 | -1.05 | -0.38 | -0.35 | Upgrade
|
| Other Expense / Income | -0.86 | 1.47 | 0.68 | 0.48 | 1.58 | -0.07 | 75.93 | 9.54 | -0.15 | 0.86 | Upgrade
|
| Pretax Income | -3.77 | -4.38 | -5.21 | -3.51 | -6.05 | -6.58 | -29.71 | -5.9 | -4.67 | -3.13 | Upgrade
|
| Income Tax | -0 | -0.01 | 0.59 | 0.51 | 1.66 | 0 | -37.96 | -4.77 | 0.07 | -0.43 | Upgrade
|
| Net Income | -3.77 | -4.37 | -5.8 | -4.01 | -7.71 | -6.51 | -29.71 | -5.9 | -4.67 | -3.13 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 7 | 6 | 5 | 4 | 3 | 233 | 170 | 2 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 7 | 6 | 5 | 4 | 3 | 233 | 170 | 2 | 1 | Upgrade
|
| Shares Change | 15.92% | 10.90% | 20.70% | 52.64% | 40.58% | -98.92% | 36.67% | 10849.17% | 11.96% | 18.31% | Upgrade
|
| EPS (Basic) | -0.45 | -0.61 | -0.89 | -0.75 | -2.19 | -2.60 | -0.13 | -0.03 | -3.00 | -2.25 | Upgrade
|
| EPS (Diluted) | -0.45 | -0.61 | -0.89 | -0.75 | -2.19 | -2.60 | -0.13 | -0.03 | -3.00 | -2.25 | Upgrade
|
| Free Cash Flow | -1.85 | -2.04 | -3.59 | -2.16 | -3.06 | -1.88 | -2.54 | -2.32 | 0.05 | 0.17 | Upgrade
|
| Free Cash Flow Per Share | -0.22 | -0.28 | -0.55 | -0.40 | -0.87 | -0.75 | -0.01 | -0.01 | 0.03 | 0.12 | Upgrade
|
| Gross Margin | -164.61% | 92.85% | 87.82% | 21.75% | 66.01% | 54.61% | 50.76% | 75.00% | 83.57% | 81.13% | Upgrade
|
| Operating Margin | -4194.50% | -1360.12% | -9389.92% | -2468.87% | -1860.58% | -1228.18% | -439.84% | -310.93% | -553.45% | -260.70% | Upgrade
|
| Profit Margin | -4224.89% | -2043.30% | -12021.81% | -3274.31% | -3208.32% | -1728.87% | -4519.55% | -841.30% | -504.58% | -267.12% | Upgrade
|
| Free Cash Flow Margin | -2078.60% | -954.81% | -7432.17% | -1762.42% | -1273.51% | -499.55% | -386.96% | -329.93% | 5.18% | 14.28% | Upgrade
|
| EBITDA | -3.54 | -2.95 | -4.33 | -2.83 | -4.33 | -4.37 | -40.82 | -6.92 | -4.92 | -3.35 | Upgrade
|
| EBITDA Margin | -3970.26% | -1379.13% | -8979.39% | -2306.93% | -1801.18% | -1159.86% | -6210.57% | -986.32% | -531.83% | -285.68% | Upgrade
|
| Depreciation & Amortization | 0.2 | 0.14 | 0.17 | 0.17 | 0.1 | 0.01 | 0.03 | 0.03 | 0.13 | 0.14 | Upgrade
|
| EBIT | -3.74 | -3.09 | -4.5 | -3 | -4.42 | -4.38 | -40.85 | -6.95 | -5.04 | -3.48 | Upgrade
|
| EBIT Margin | -4194.50% | -1445.52% | -9329.37% | -2442.93% | -1841.34% | -1161.81% | -6215.73% | -990.63% | -545.36% | -297.25% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.